Medivir AB Signs Dengue Deal with Johnson & Johnson Published: Feb 14, 2011 Pharma Times -- Sweden's Medivir has signed a collaboration with Johnson & Johnson unit Janssen Pharmaceutica to develop treatments for dengue virus infection. Related links Genetic Engineering & Biotechnology News This will open in a new window Pharma Times [Free Reg Req'd] This will open in a new window News Release This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news